Approval · Notice of Compliance 29981 · 2023
OTIXAL: Notice of Compliance 29981
Issued January 25, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29981
- Date
- January 25, 2023
- Company
- Medexus Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OTIXAL | 02459655 | Marketed |
Medicinal ingredients
- FLUOCINOLONE ACETONIDE 0.3 PER
- CIPROFLOXACIN 0.025 PER